Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical Trial
Reason given: We were informed by the NCI that this research no longer aligns with NCI values, therefore our grant was terminated and we had received a stop work order.
Key facts
- Where
- Boston, United StatesSee the site
Where in United States
- Boston Medical CenterBoston, United StatesNo longer taking part
Trial details
- Who runs it
- Tufts Medical Center
- Trial code
- NCT06367699
- Record updated
- 15 July 2025
- Original description
The objective of this study is to assess the use of and satisfaction with the ECA-HPV intervention over a 16-month period, its ability to increase HPV vaccination, and the comparative effectiveness of clinic notification and adolescent ECA components on these factors.Read full original descriptionShow less
Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care
The objective of this study is to assess the use of and satisfaction with the ECA-HPV intervention over a 16-month period, its ability to increase HPV vaccination, and the comparative effectiveness of clinic notification and adolescent ECA components on these factors.
Inclusion: For parent/guardian participants:; Speaks English fluently; Able to independently consent; Has adequate corrected vision to use the ECA-HPV system (based on their ability to go through the consent form); Has adequate hearing to use the ECA-HPV system (based on their ability to hear the research staff member conducting the consent process); Has a smartphone that is able to support the ECA-HPV app; For adolescent participants:; Is between the ages of 9-12 at the time of the index (first) well child visit; Has received either 1 or none of the HPV vaccine series; Speaks English fluently; Able to independently assent; Has adequate corrected vision to use the ECA-HPV system; Has adequate hearing to use the ECA-HPV system; Has a smartphone or has access to parent/guardian's smartphone (that is able to support the ECA-HPV app); Has an upcoming well child visit at Boston Medical Center.
Exclusion: Is not able to use the ECA-HPV system; Has already participated in the study before.